🇺🇸 FDA
Patent

US 7998926

Dimerized T-cell receptor fragment, its compositions and use

granted A61KA61K38/00A61P

Quick answer

US patent 7998926 (Dimerized T-cell receptor fragment, its compositions and use) held by The Arizona Boad of Regents on Behfl of the University of Arizona expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Arizona Boad of Regents on Behfl of the University of Arizona
Grant date
Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61P, A61P37/02